Objective: To assess the functionality and patient acceptability of HumaPen Ergo ®, a new 3.0ml reusable insulin pen. Design: Patients trialled HumaPen Ergo ® (Eli Lilly) over 5 to 7 weeks and ...

Study design. This prospective, randomized, controlled, parallel-group study compared the use of pen devices with conventional vials and syringes for the administration of insulin in hospitalized ...